5 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
SNY vs. NVO: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/900968/sny-vs-nvo-which-stock-is-the-better-value-option?cid=CS-ZC--tale_of_the_tape|yseop_template_3-900968 Apr 30, 2020 - SNY vs. NVO: Which Stock Is the Better Value Option?
Top Analyst Reports for Alibaba, Pfizer & S&P Global http://www.zacks.com/research-daily/868704/top-analyst-reports-for-alibaba-pfizer-sp-global?cid=CS-ZC-FT-research_daily-868704 Apr 13, 2020 - Top Analyst Reports for Alibaba, Pfizer & S&P Global
Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes http://www.zacks.com/stock/news/857383/novo-nordisks-rybelsus-gets-eu-nod-for-type-ii-diabetes?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-857383 Apr 06, 2020 - Novo Nordisk (NVO) gains the EU approval for Rybelsus to address adult patients with insufficiently-controlled type II diabetes for improving glycemic control as an adjunct to diet and exercise.
NVS vs. NVO: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/849177/nvs-vs-nvo-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-849177 Apr 01, 2020 - NVS vs. NVO: Which Stock Is the Better Value Option?
Top Analyst Reports for Alphabet, Procter & Gamble & Philip Morris http://www.zacks.com/research-daily/845014/top-analyst-reports-for-alphabet-procter-gamble-philip-morris?cid=CS-ZC-FT-research_daily-845014 Mar 30, 2020 - Top Analyst Reports for Alphabet, Procter & Gamble & Philip Morris

Pages: 1

Page 1